Biosimilar Newsletter Archive
-
06.20.24 -- Achieving Seamless Tech Transfer With Your CDMO
6/20/2024
06/20/24 Biosimilar Development Newsletter
-
06.20.24 -- Celltrion Showcases Promising Results For Biosimilar RoActemra In RA
6/20/2024
06/20/24 Biosimilar Development Newsletter
-
06.19.24 -- Blended Learning – Can It Boost Operator Engagement And Reduce Errors?
6/19/2024
06/19/24 Biosimilar Development Newsletter
-
06.13.24 -- Elevate Your Chromatography Scale-Up Process
6/13/2024
06/13/24 Biosimilar Development Newsletter
-
06.13.24 -- FDA Accepts Denosumab Biosimilar BLA For Review
6/13/2024
06/13/24 Biosimilar Development Newsletter
-
06.06.24 -- Accelerate The mAb Formulation Process
6/6/2024
06/06/24 Biosimilar Development Newsletter
-
05.30.24 -- Injectable Medications: How To Stay Relevant & Patient Centric
5/30/2024
05/30/24 Biosimilar Development Newsletter
-
05.23.24 -- Minimize Waste, Maximize Yield And Supor Charge Your Production Process
5/23/2024
05/23/24 Biosimilar Development Newsletter
-
05.23.24 -- Tech Advancements For Upstream Bioprocessing
5/23/2024
05/23/24 Biosimilar Development Newsletter
-
05.16.24 -- Integrating Quality Processes And Documentation After A Merger
5/16/2024
05/16/24 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more